University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Nutrition and Health Sciences -- Faculty
Publications

Nutrition and Health Sciences, Department of

2014

The Effects of Polyethylene Glycosylated Creatine
Supplementation on Anaerobic Performance
Measures and Body Composition
Clayton L. Camic
University of Wisconsin-La Crosse, ccamic@uwlax.edu

Terry J. Housh
University of Nebraska-Lincoln, thoush1@unl.edu

Jorge M Zuniga
Creighton University, jorgezuniga@creighton.edu

Daniel A. Traylor
University of Nebraska-Lincoln

Haley Bergstrom
University of Nebraska-Lincoln, hbergstrom@uky.edu
See next page for additional authors

Follow this and additional works at: http://digitalcommons.unl.edu/nutritionfacpub
Part of the Human and Clinical Nutrition Commons, Molecular, Genetic, and Biochemical
Nutrition Commons, and the Other Nutrition Commons
Camic, Clayton L.; Housh, Terry J.; Zuniga, Jorge M; Traylor, Daniel A.; Bergstrom, Haley; Schmidt, Richard J.; Johnson, Glen O.; and
Housh, Dona J., "The Effects of Polyethylene Glycosylated Creatine Supplementation on Anaerobic Performance Measures and Body
Composition" (2014). Nutrition and Health Sciences -- Faculty Publications. 88.
http://digitalcommons.unl.edu/nutritionfacpub/88

This Article is brought to you for free and open access by the Nutrition and Health Sciences, Department of at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Nutrition and Health Sciences -- Faculty Publications by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.

Authors

Clayton L. Camic, Terry J. Housh, Jorge M Zuniga, Daniel A. Traylor, Haley Bergstrom, Richard J. Schmidt,
Glen O. Johnson, and Dona J. Housh

This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/nutritionfacpub/88

Published in Journal of Strength and Conditioning Research 28:3 2014, pp. 825-833.
Copyright © 2014 National Strength and Conditioning Association; published by NSCA. Used by permission.
digitalcommons.unl.edu

The Effects of Polyethylene Glycosylated Creatine Supplementation
on Anaerobic Performance Measures and Body Composition
Clayton L. Camic,1 Terry J. Housh,2 Jorge M. Zuniga,3 Daniel A. Traylor,2
Haley C. Bergstrom,2 Richard J. Schmidt,2 Glen O. Johnson,2 and Dona J. Housh4
1 Department of Exercise and Sport Science, Human Performance Laboratory,
University of Wisconsin-La Crosse, La Crosse, Wisconsin
2 Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska
3 Department of Exercise Science, Creighton University, Omaha, Nebraska
4 Department of Oral Biology, University of Nebraska Medical Center, Lincoln, Nebraska
Corresponding author – Clayton L. Camic, email ccamic@uwlax.edu

Abstract

The purpose of this study was to examine the effects of 28 days of polyethylene glycosylated creatine (PEG-creatine) supplementation (1.25 and 2.50 g · d-1) on anaerobic performance measures (vertical and broad jumps, 40-yard dash, 20-yard
shuttle run, and 3-cone drill), upper- and lower-body muscular strength and endurance (bench press and leg extension),
and body composition. This study used a randomized, double-blind, placebo controlled parallel design. Seventy-seven adult
men (mean age ± SD, 22.1 6 2.5 years; body mass, 81.7 ± 10.8 kg) volunteered to participate and were randomly assigned
to a placebo (n = 23), 1.25 g · d-1 of PEG-creatine (n = 27), or 2.50 g · d-1 of PEG-creatine (n = 27) group. The subjects performed anaerobic performance measures, muscular strength (one-repetition maximum [1RM]), and endurance (80% 1RM)
tests for bench press and leg extension, and underwater weighing for the determination of body composition at day 0 (baseline), day 14, and day 28. The results indicated that there were improvements (p , 0.0167) in vertical jump, 20-yard shuttle run, 3-cone drill, muscular endurance for bench press, and body mass for at least one of the PEG-creatine groups without changes for the placebo group. Thus, the present results demonstrated that PEG-creatine supplementation at 1.25 or
2.50 g · d-1 had an ergogenic effect on lower-body vertical power, agility, change-of-direction ability, upper-body muscular
endurance, and body mass.
Keywords: PEG, supplements, strength, endurance

Introduction

regarding the influence of creatine supplementation on
standardized field assessments of power, lateral speed,
agility, and change-of-direction ability that are commonly
used to predict athletic performance. Based on the shortduration high-intensity nature of frequently used tests
such as the broad and vertical jumps, 40-yard dash, 20yard shuttle run, and 3-cone drill, it is likely that supplementation with creatine would serve as an effective
ergogenic aid for these activities. For example, the physiological benefits of creatine supplementation have been
attributed to enhanced adenosine triphosphate (ATP) regeneration, shortened muscle relaxation time, improved
efficiency of cross-bridge cycling (35), and body composition (17,22,28,36). Therefore, it is possible that these adaptations would facilitate the maximal, and often repetitive, muscular contractions associated with standardized
field assessments (i.e., broad and vertical jumps, 40-yard
dash, 20- yard shuttle run, 3-cone drill), thereby improving performance in these areas.

Previous investigations have shown that creatine supplementation provides an ergogenic effect for various measures of anaerobic exercise performance. In particular, it
has been demonstrated that short-term loading (20–25 g
· d-1, 5–7 days) or long-term chronic doses (3 g· d-1, ≥30
days) of creatine monohydrate (CM) can lead to improvements in one-repetition maximum (1RM) strength, muscular endurance, anaerobic power, speed, and sprinting performance (5,15,17,19,22,24,25,32–34,36). Traditionally, the
methods used to assess these variables include dynamic
constant external resistance exercises (i.e., free weights,
weight machines) and anaerobic performance measures
such as the Wingate test (5,15,19). In addition, the majority of these studies (5,15,17,19,22,24,25,32–34,36) have included resistance training during the supplementation period and have used cycle ergometry, not running, to assess
sprinting performance. There are limited data, however,
825
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Polyethylene glycol (PEG) is a nontoxic water-soluble
polymer that is commonly bound to various substances
and functions as a delivery system to enhance the absorption of medications (3), vitamins (23), and nutritional
supplements including creatine (5,12,19) and L-arginine
(6,7). When attached to PEG, creatine has been shown
to have greater uptake efficiency (12) and provide ergogenic effects with smaller supplementation doses compared with CM (19). Specifically, Herda et al. (19) established that supplementation with 1.25 and 2.50 g· d-1 of
PEG-creatine for 30 days without concurrent resistance
training improved measures of upper- and lower-body
strength to the same extent as 5 g · d-1 of CM. It is possible that these findings (19) were attributable, in part, to
changes in body composition leading to greater muscular
strength. In particular, recent investigations have shown
that supplementation with creatine may promote favorable effects on fat-free mass (FFM) by stimulating protein synthesis (36) and inhibiting protein catabolism (28).
Thus, in addition to the ergogenic effects related to enhanced ATP regeneration and subsequent ability to maintain high-intensity exercise, PEG-creatine supplementation may provide improvements in body composition
that are not associated with those of resistance training.
Based on these mechanisms, it is possible that supplementation with PEG-creatine would improve the short-duration, high-intensity standardized field assessments of anaerobic performance. Therefore, the purpose of this study
was to examine the effects of 28 days of PEG-creatine supplementation (1.25 and 2.50 g· d-1) on anaerobic performance measures (vertical and broad jumps, 40-yard dash,
20-yard shuttle run, and 3-cone drill), upper- and lowerbody muscular strength and endurance (bench press and
leg extension), and body composition.
Methods
Experimental Approach to the Problem
This study used a randomized, double-blind, placebo controlled parallel design. During the first laboratory visit,
each subject performed anaerobic performance measures
including vertical jump, broad jump, 40-yard dash, 20-yard
shuttle run, and 3-cone drill that have commonly been used
at the National Football League Scouting Combine. Procedures used for these anaerobic performance measures
were consistent with those previously reported (26,29,30).
After 24 hours, each subject returned to the laboratory to
complete the second visit (day 0) that involved assessment
of muscular strength (1RM) and endurance (maximal number of repetitions completed at 80% 1RM) for the bench
press and bilateral leg extension exercises. In addition,
during the second laboratory visit, each subject performed
underwater weighing for the determination of body composition and was randomly assigned to one of 3 groups: (a)
placebo (n = 23); (b) 1.25 g · d–1 of PEG-creatine (PEG1.25;

n = 27); or (c) 2.50 g · d–1 of PEG-creatine (PEG2.50; n =
27). The ingredients for the supplement included 1.25 g or
2.50 g of PEG-creatine, whereas the placebo consisted of
microcrystalline cellulose. The subjects were asked to ingest 1 dose (4 tablets) every day with approximately 0.5
L of water for 28 days. After 2 weeks of supplementation
(day 14), the subjects returned to the laboratory for visits 3 and 4 (separated by 24 hours) to perform the anaerobic performance measures, muscular strength and endurance exercises, and underwater weighing using the same
protocol as during the baseline measurements. After 2 additional weeks of supplementation (day 28), the testing
procedures were repeated during the fifth and sixth laboratory visits (separated by 24 hours). During the course of
the study, the subjects were encouraged to continue with
their normal exercise and dietary habits. Subjects were
also instructed to refrain from exercise for 48 hours before each laboratory visit. Furthermore, each subject completed a 3-day food log during the first and last week of
the supplementation period to ensure there were no significant changes in total caloric (kcal), protein, carbohydrate, and fat intake.
Subjects
Seventy-seven adult men (mean age ± SD, 22.1 ± 2.5 years;
body mass, 81.7 ± 8.4 kg; height, 181.7 ± 5.3 cm) volunteered to participate in this investigation. The subjects
were untrained in resistance exercise and engaged in no
more than 4 hours of recreational activity per week. All of
the subjects were University of Nebraska undergraduate or
graduate students. Data collection was performed during
the fall semester. In addition, the subjects did not report
or exhibit any of the following that could have significantly
affected the outcome of the study: (a) a history of medical
or surgical events, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders; (b)
use of any medication; (c) use of nutritional supplements;
or (d) participation in another clinical trial or ingestion
of another investigational product within thirty days before screening/ enrollment. The study was approved by the
University Institutional Review Board for Human Subjects,
and all participants completed a health history questionnaire and signed a written informed consent document before the testing.
Procedures
Vertical Jump. Vertical jump height was measured using
the Vertec vertical jump device (Gill Athletics, Champaign,
IL, USA). Each subject was positioned directly underneath
the Vertec and instructed to jump as high as possible from
a standing 2-foot position and move the highest horizontal vane with a single hand (29). Each subject performed
3 vertical jumps with 2 minutes of rest between each trial.
Vertical jump height was calculated as the difference between the highest vane of the Vertec reached and the
standing reach height.
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Broad Jump.
The standing broad jump test involved each subject standing in a 2-foot position with their toes directly behind the
starting line and jumping forward for maximal horizontal
distance. The standing broad jump distance was measured
as the farthest horizontal distance reached by the landing contact point of the heel from the starting line (29).
Each subject performed 3 standing broad jump trials with
2 minutes of rest between each trial.
40-Yard Dash.
The 40-yard dash involved measuring the time (hand timed
by the same investigator) required to sprint 40 yards as
fast as possible. Each subject was positioned in a 3- point
stance behind the starting line and was instructed to sprint
the distance of 40 yards as fast as possible. Two cones
were used to represent the starting line, and 2 cones were
placed 40 yards down field to represent the finishing line
that each subject was instructed to run through. Subjects
performed two 40-yard dash time trials separated by 2
minutes with the fastest time used as the representative
40-yard dash time.
20-Yard Shuttle Run.
The shuttle run involved each subject completing 20 total yards of lateral movement with 2 changes in direction
in the fastest time possible. The starting position involved
each subject straddling the middle of 3 parallel lines spaced
5 yards apart from one another. From the starting (middle)
line, the subject ran 5 yards to the right, touched the farthest right line with their right hand, quickly changed direction, and ran 10 yards back to the left passing the starting line. After reaching down and touching the far left line
with their left hand, the subject again changed direction
and sprinted 5 yards to the right passing the starting line
(29). Each subject performed 2 trials separated by 2 minutes of rest. The shuttle run time was recorded as the fastest time required to complete the 20-yard course.
3-Cone Drill.
The 3-cone drill involved each subject running a specific
route around 3 cones placed 5 yards apart in an “L” formation (30). Each subject performed 2 trials separated by 2
minutes of rest. The fastest time required to complete the
course was used as the representative 3-cone drill time.
Muscular Strength and Endurance.
The 1RM dynamic constant external resistance (DCER)
muscular strength was determined for the leg extension
(1RMLE) and bench press (1RMBP) exercises. The leg extension exercises were performed on a plate-loaded leg extension resistance training machine (Body-Solid, Forest Park,
IL, USA). Each subject sat with their back flat against the
backrest and was instructed to hold tightly to the handles
of the device. The backrest was adjusted to align the anatomical axes of the knee with the mechanical axis of the
machine. The subject’s legs were placed against shin pads
that were attached to the lever arm of the machine. The
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distance between the shin pads and the axis of rotation
of the lever arm was fixed and not adjustable. The positioning of each subject, however, was consistent across
all tests. The bench press exercises were performed on a
standard free-weight bench (Body Power, Williamsburg,
VA, USA) with an Olympic bar. After receiving a lift-off
from a spotter, the subject lowered the bar to their chest,
paused briefly, and then pressed the bar to full extension
of the forearms. For both the leg extension and bench press
exercises, 1RM DCER strength was determined by applying progressively heavier loads until the subject could not
complete a repetition through the full range of motion. Additional trials were performed with lighter loads until the
1RM was determined within 2.27 kg, and this was typically
achieved within 5 trials. Two minutes of rest were allowed
between all trials. For the leg extension (REPLE) and bench
press (REPBP) endurance testing, subjects performed as
many repetitions as possible of full extension of the legs
and forearms at 80% of their baseline (day 0) 1RM. During day 0, day 14, and day 28, the same procedures for leg
extension and bench press testing were performed. The
test-retest reliability data from our laboratory for leg extension and bench press strength testing indicated that for
adult male subjects (n = 20) measured 8 weeks apart, the
intraclass correlations (ICC) were 0.98 and 0.99, respectively, with no significant (p > 0.05) mean differences between test and retest values.
Underwater Weighing.
Body density was assessed from underwater weighing
(UWW), with correction for residual lung volume (RV) using the oxygen dilution method of Wilmore (38). Residual lung volume was determined with the subject seated
in a position similar to that assumed during UWW. The average of similar scores (within 100 mL) from 2 to 3 trials
was used as the representative RV. Underwater weight was
measured in a hydrostatic weighing tank in which a nylon
swing seat was suspended from a 10-kg Salter scale (REGO
Designs & Patents, model 230). The average of the 3 highest values from 6 to 10 trials was used as the representative underwater weight. Percent body fat (% fat) was calculated using the formula of Brozek et al. (4), with fat mass
and FFM derived mathematically. Previous test retest reliability data for UWW from our laboratory for % fat indicated that for young adult male subjects (n = 16) measured
24–72 hours apart, the ICC was 0.98, with a standard error
of measurement of 0.9% fat and no significant (p > 0.05)
mean differences between test and retest values.
Statistical Analyses
Vertical jump, broad jump, 40-yard dash, 20-yard shuttle run, and 3-cone drill times as well as 1RMBP, 1RMLE,
REPBP, REPLE, body mass, % fat, fat mass, FFM, were analyzed with separate 3 X 3 mixed factorial analysis of
variance (ANOVAs) (time [day 0, day 14, day 28] X group
[placebo, 1.25 g · d–1, 2.50 g· d-1]). In addition, 1-way follow-up repeated measures ANOVAs across time for a priori
planned comparisons by group were conducted and post

67.1 (1.2)

13.4 (1.3)

16.1 (1.1)

80.5 (2.3)

17.0 (1.4)

109.8 (5.5)*

8.5 (0.3)

88.4 (4.1)*

8.23 (0.09)

4.92 (0.05)

† Significantly different from day 14.

* Significantly (P < 0.0167) different from day 0.

Values are expressed as mean (SE).
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16.2 (1.2)

80.2 (2.3)
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8.0 (0.4)
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8.14 (0.22)

5.27 (0.21)

67.5 (1.3)*

13.0 (1.2)

15.7 (1.0)

80.5 (2.4) 7

18.6 (1.8)*

112.0 (4.8)*

8.9 (0.4)

89.2 (4.1)*

8.23 (0.07)

4.88 (0.05)

67.8 (1.4)

12.0 (1.2)

9.8 (2.0)

14.6 (1.2)

12.8 (0.8)

104.0 (3.4)

7.4 (0.6)

89.3 (4.0)

8.44 (0.08)

5.04 (0.05)

68.2 (1.4)

12.0 (1.1)

14.5 (1.1)

80.2 (2.0)

16.8 (1.4)*

115.1 (4.3)*

8.6 (0.4)

91.9 (4.1)*

8.30 (0.08)

5.03 (0.05)

69.0 (1.4)*†

11.7 (1.1)

14.1 (1.1)

80.7 (2.0)*

19.7 (1.6)*†

121.5 (4.6)*

9.3 (0.5)*

93.1 (4.0)*

8.29 (0.08)

4.83 (0.04)*†

67.7 (1.5)

13.6 (1.3)

16.3 (1.3)

81.3 (2.1)

12.8 (1.0)

100.0 (4.8)

8.7 (0.5)

88.5 (4.0)

8.55 (0.09)

5.08 (0.06)

68.6 (1.5)*
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16.2 (1.2)
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16.9 (1.5)*

111.4 (4.7)*
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91.0 (3.7)*

8.31 (0.07)*
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69.0 (1.5)*
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16.2 (1.3)
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92.8 (3.7)*†

8.31 (0.08)*

4.86 (0.05)*†

5.23 (0.06)*†

237.3 (4.9)*†

61.0 (2.0)*

Day 28

5.40 (0.06)*

229.9 (4.5)

59.7 (1.9)

Day 14

PEG2.50 (n = 27)

5.60 (0.08)

229.6 (5.7)

58.7 (1.8)

Day 0

5.13 (0.06)*†

241.9 (3.2)*

65.8 (1.4)*

Day 28

5.24 (0.05)*

238.0 (3.2)

65.5 (1.4)*

Day 14

PEG1.25 (n = 27)

5.43 (0.06)

236.0 (3.5)

63.0 (1.5)

Day 0

5.27 (0.06)*

234.1 (3.8)*

60.7 (1.8)

Day 28

5.33 (0.06)*

232.6 (4.3)*

60.0 (1.9)

Day 14

5.53 (0.07)

228.2 (3.9)

58.9 (1.8)

Day 0

1RM = 1 repetition maximum.

Fat-free mass (kg)

Fat mass (kg)

Body fat (%)

Body mass (kg)

(repetitions to failure)

Leg extension endurance

Leg extension 1RM (kg)

(repetitions to failure)

Bench press endurance

Bench press 1RM (kg)

3-cone drill (s)

Shuttle run (s)

40-yard dash (s)

Broad jump (cm)

Vertical jump (cm)

		

Placebo (n = 23)

polyethylene glycosylated creatine (PEG2.50) groups.

Table 1. Physical characteristics and performance measures at day 0, 14, and 28 for the placebo, 1.25 g· d-1 polyethylene glycosylated creatine (PEG1.25),and 2.50 g· d-1

828
C a m i c e t a l . , in Jou rna l of Strength a nd Condi ti oni ng Resea rch 28 ( 2014)

E f f e c t s o f P o ly e t h y l e n e G lyc o s y l at e d C r e at i n e S u p p l e m e n tat i o n

hoc analyses included paired sample t-tests with Bonferroni corrections (0.05/3 = 0.0167). An alpha of p < 0.05
was considered statistically significant for all interaction
effects and follow-up ANOVAs. In addition, the total caloric
(kilocalories) and macronutrient (grams of protein, carbohydrate, and fat) intake were analyzed with separate 2
(time [day 0, day 28]) X 3 (group [1.25 g · d–1, 2.50 g · d–1,
placebo]) mixed factorial ANOVAs.
Results
The results of the statistical analyses for the performance
measures at day 0, 14, and 28 for the placebo, PEG1.25, and
PEG2.50 groups are provided in Table 1. The findings indicated that there were significant increases in vertical
jump (PEG1.25 and PEG2.50), REPBP (PEG1.25 and PEG2.50),
and body mass (PEG1.25 and PEG2.50), without changes for
the placebo group. There were also significant decreases
in the 20-yard shuttle run (PEG1.25 and PEG2.50) and 3-cone
drill (PEG2.50), without changes for the placebo group. For
broad jump, 40-yard dash, 1RMBP, 1RMLE, REPLE, and FFM,
however, there were changes for all 3 groups (placebo,
PEG1.25, and PEG2.50). There were no changes in % fat, fat
mass, total calories, or macronutrients consumed for any
of the groups.
Discussion
The findings of the present investigation indicated that
supplementation with 1.25 or 2.50 g · d–1 of PEG-creatine
led to significant improvements in vertical jump, 20-yard
shuttle run, 3-cone drill, REPBP, and body mass (Table 1).
For broad jump, 40-yard dash, 1RMBP, 1RMLE, REPLE, and
FFM, however, there were no significant differences among
both PEG-creatine groups (1.25 and 2.50 g· d21) and the
placebo group. Thus, the results of this study demonstrated
that PEG-creatine supplementation had an ergogenic effect
on lower-body vertical power, upper-body muscular endurance, agility, change-of-direction ability, and body mass,
but not on speed, upper-body muscular strength, lowerbody horizontal power, muscular strength, or endurance.
In general, previous studies (21,27) have shown that
short-term creatine supplementation without resistance
training had no influence on vertical jump performance.
For example, Izquierdo et al. (21) found that 5 days of
loading (20 g · d–1) with CM did not improve vertical jump
height in a sample of male handball players (n = 19). Mujika et al. (27) also determined that 6 days of CM loading
(20 g · d–1) resulted in no change in vertical jump (47.4 6
6.0 cm to 46.8 6 6.0 cm) in male soccer athletes (n = 17).
It has been suggested (27) that short-term creatine loading may not be beneficial for performances related to overcoming gravity such as vertical jump, because of the associated increase in body mass caused by water retention.
Furthermore, because of the short duration (i.e., ,1 second) in performing a vertical jump, it is likely that phosphocreatine stores are not the limiting factor for this activity, and therefore, may not be influenced by CM loading
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(25). In combination with resistance training, how ever,
longer-term supplementation with creatine may lead to
improvements in vertical jump as the result of increased
FFM (27,32). This suggestion is supported by the findings of Haff et al. (17) and Kirksey et al. (22) that demonstrated concurrent increases in vertical jump performance
and FFM after 6 weeks of creatine supplementation (0.3
g · kg-1 · d-1) and resistance training in track and field athletes. In this investigation, there were significant increases
in vertical jump after 28 days of supplementation for the
PEG1.25 (63.0 ± 1.5 cm to 65.8 ± 1.4 cm) and PEG2.50 (58.7
± 1.8 cm to 61.0 ± 2.0 cm) groups, but no change (58.9 ±
1.8 cm to 60.7 ± 1.8 cm) in the placebo group. Therefore,
although we did not use a concurrent resistance training
program, it is possible that the changes in vertical jump for
the PEGcreatine groups were related to the increased FFM
(PEG1.25: 67.8 ± 1.4 kg to 69.0 ± 1.4 kg; PEG2.50: 67.7 ± 1.5
kg to 69.0 ± 1.5 kg) from day 0 to day 28. In contrast, however, the placebo group also exhibited increased FFM (66.7
± 1.2 kg to 67.5 ± 1.3 kg) over the same time period, but
experienced no improvement in vertical jump. It is possible that these findings were related to the amount of absolute change in FFM among the PEG1.25 (+1.2 kg), PEG2.50
(+1.3 kg), and placebo groups (+0.8 kg). The present results also indicated that there were no improvements in
broad jump performance at day 14 or day 28 for the PEG1.25
or PEG2.50 groups when compared with the placebo group.
Both vertical jump and broad jump have been described
as measures of lower-body power and have been shown to
be moderately correlated (r = 0.74) (29). Based on these
findings (29), we hypothesized that the creatine-induced
changes in performance would be similar between vertical jump and broad jump. The mechanism responsible for
the discrepancy in the results remains uncertain, but may
have been because of the relatively smaller doses of PEGcreatine (1.25 and 2.50 · g d-1) used in this study compared
with previous investigations (22,24,25,34,36) that have
used large loading doses of CM and shown improvements
in lower body power. Future studies should further examine the effects of PEG-creatine on vertical and broad jump
performance using larger doses or longer supplementation periods.
The results of this investigation indicated there were
significant decreases in 40-yard dash time from day 0 to
day 28 for the PEG1.25 (5.43 ± 0.06 seconds to 5.13 ± 0.06
seconds) and PEG2.50 (5.60 ± 0.08 seconds to 5.23 ± 0.06
seconds) groups as well as the placebo group (5.53 ± 0.07
seconds to 5.27 ± 0.06 seconds). In general, the findings of
previous studies (11,14,32) have suggested that the ergogenic effect of creatine supplementation on sprinting performance may vary based on differences in training status, athletic sample examined, sprint distance assessed,
or addition of a concurrent resistance training program.
For example, Glaister et al. (14) found no improvements
for 30-meter dash time after 5 days of loading with CM
(20 g · d–1) in a sample (n = 21) of college-aged men who
regularly participated in multiple sprint activities. Delecluse et al. (11) also reported no change in 40-meter dash
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performance (5.09 ± 0.09 seconds to 5.08 ± 0.10 seconds)
after 7 days of loading (0.35 g · kg-1 · d-1) with CM in elite
college sprinters (n = 7). The authors (11) contented that
the mechanisms underlying the benefits of creatine supplementation may already be optimized in highly trained
sprinters because of multiple years of intensive sprint
training. This suggestion (11), however, is not consistent
with the findings of Skare et al. (31) that indicated 20 g ·
d-1 of CM for 5 days decreased 60-m and 100-m (11.68 ±
0.27 seconds to 11.59 ± 0.31 seconds) times in a sample
of sprinters (n = 9) during a concurrent resistance training program. Stout et al. (32) also found improvements
in 100-yard dash time (12.13 ± 0.36 seconds to 11.82 ±
0.37 seconds) after 8 weeks of supplementation with CM
(21 g · d-1 for 5 days, 10.5 g · d-1 thereafter) in resistancetrained college football players. It has been demonstrated
that creatine supplementation with resistance training
provides greater improvements in performance compared
with just creatine supplementation or resistance training
alone (1). These findings (1) offer a plausible explanation
for the ergogenic effects observed after supplementation
with CM in the resistance-trained athletes of Stout et al.
(32) and Skare et al. (31) compared with the lack of improvement in the participants of this investigation and previous studies (11,14) who were not engaged in a concurrent resistance training program during the course of the
study. In conjunction, the present findings and those of
others (11,14,31,32) suggested that creatine supplementation may improve 40- and 100-yard dash performance only
when combined with resistance-training.
To the best of our knowledge, no previous investigations have examined the effects of creatine supplementation on the 20-yard shuttle run and 3-cone drill, which
have been described as performance measures related to
anaerobic power, speed, change-of-direction ability, and
agility (26,29). Our results demonstrated there were significant decreases in shuttle run times for the PEG1.25 group
from day 0 (5.04 ± 0.05 seconds) and day 14 (5.03 ± 0.05
seconds) to day 28 (4.83 ± 0.04 seconds); and PEG2.50
group from day 0 (5.08 ± 0.06 seconds) to day 14 (4.97 ±
0.04 seconds) day 28 (4.86 ± 0.05 seconds). In addition,
there were significant decreases in 3-cone drill time for the
PEG2.50 group from day 0 (8.55 ± 0.09 seconds) to day 14
(8.31 ± 0.07 seconds) and day 28 (8.31 ± 0.08 seconds),
but not the PEG1.25 or placebo groups. The physiological
mechanisms that were responsible for faster 20-yard shuttle run and 3-cone drill performances may be related to the
shortened muscle relaxation time associated with CM supplementation (35). Specifically, the findings of van Leemputte et al. (35) suggested that greater intracellular stores
of phosphocreatine would lead to improved efficiency of
sarcoplasmic Ca++-ATPase activity and cross-bridge cycling, thereby decreasing the energy costs of human skeletal muscle relaxation. It is possible that these adaptations
would contribute to increased power production by skeletal muscle and enable maximal, high-intensity muscular
contractions to continue for a greater period of time (35).

In theory, the proposed mechanisms would facilitate the
rapid and repeated muscle actions required during the 20yard shuttle run and 3-cone drill, leading to enhanced performance in these activities. Future studies should further
examine the effects of creatine supplementation on physical measures involving multiple high-intensity muscular
contractions associated with change-of-direction ability
and agility. The findings of this study, however, indicated
that supplementation with 2.50 g · d-1 of PEG-creatine provided an ergogenic effect for the 20-yard shuttle run and
3-cone drill.
Recent investigations (13,34,39) have reported conflicting results regarding the effect of creatine supplementation without concurrent resistance training on muscular
strength. For example, it has been demonstrated that 25
g · d-1 of CM for 5 days increased concentric, isokinetic
peak torque of the leg extensors at 1808 · s-1(34), but 20
g · d-1 over the same time period resulted in no change
(13). In addition, loading doses of 20 g · d-1 for 5 days have
been shown to increase 1RM half-squat, but not 1RMBP (21).
Zuniga et al. (39) also examined loading doses of 20 g · d-1
of CM and found no improvements in 1RMLE or 1RMBP after 7 days of supplementation. Other studies (5,19) involving non-loading chronic doses of PEG-creatine (1.25–5.00
g · d-1) and the assessment of muscular strength have also
provided inconsistent results, particularly between upperand lower-body 1RM measures. Specifically, 4 weeks of
supplementation with 1.25, 2.50, and 5.00 g · d-1 of PEGcreatine has been shown to improve 1RMBP (5,19). For
measures of lower body strength, however, these investigations found that 1.25 and 2.50 g · d–1 increased 1RM leg
press (19), but 5.0 g · d-1 had no effect on 1RMLE (5). In
this investigation, there were increases in both 1RMBP and
1RMLE from day 0 to day 28 for the PEG1.25, PEG2.50, and
placebo groups. Collectively, the present findings and those
of others (5,13,19,21,34,39) indicated that chronic doses
(1.25–5.0 g · d-1) of PEG-creatine and loading doses of CM
up to 20 g · d–1 may not improve lower-body strength when
assessed with the leg extension exercise. Furthermore, in
contrast to Herda et al. (19), the results of this investigation also demonstrated that supplementation with 1.25
and 2.50 g · d-1 of PEG-creatine, like loading doses of CM
(20 g · d-1) (21,39), may not increase upper-body muscular strength without resistance training.
Creatine supplementation largely benefits exercise
performance through enhanced levels of phosphocreatine within the muscle that facilitate the regeneration
of ATP from ADP by means of creatine kinase. Therefore,
this mechanism would primarily be useful during repeated
bouts of high intensity activity and enable larger volumes
of work to be accomplished during resistance training with
subsequent increases in muscular strength and endurance.
Previous studies have shown that typical loading periods
(20 g · d-1 for 5–7 days) (18) and smaller chronic doses
(3 g · d-1 for 28 days) (20) of CM can elevate intramuscular phosphocreatine and total creatine stores to ergogenic
levels. In addition, Fry et al. (12) demonstrated through
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biopsies that 10 g · d-1 of PEG-creatine was associated with
a significantly greater creatine uptake efficiency in skeletal muscle compared with 20 g · d-1 of CM over a 5-day supplementation period. Therefore, the authors (12) suggested
that relatively smaller doses of PEG-creatine may improve
measures of exercise performance to similar levels compared with larger doses of CM. Subsequently, Herda et al.
(19) established that 30 days of supplementation with 1.25
and 2.50 g · d-1 of PEG-creatine provided ergogenic effects on 1RMBP and 1RM leg press equal to those from 5.0
g · d-1 of CM. Based on these findings (12,19), we hypothesized that 28 days of supplementation with the current
PEG-creatine doses (1.25 and 2.50 g · d-1) would result in
increased 1RMBP and 1RMLE. The physiological mechanism
associated with PEG-creatine supplementation that is responsible for improving 1RMBP and 1RM leg press, but not
1RMLE remains uncertain. Specifically, dosing regimens
as low as 1.25 g · d-1 of PEG-creatine have resulted in increased 1RMBP and 1RM leg press; whereas, 1.25–5.00 g ·
d-1 has not led to improved 1RMLE. Thus, the present findings and those of others (5,13,19,34,39) have indicated that
supplementation with PEG-creatine or CM may not influence measures of upper- and lower-body strength in similar manners.
In this investigation, muscular endurance was assessed
as the maximum number of repetitions completed using
80% of the baseline (day 0) 1RM for both bench press and
leg extension. Our results indicated that there were increases in REPBP from day 0 to day 28 for the PEG1.25 (7.4
± 0.6 to 9.3 ± 0.5) and PEG2.50 (8.7 ± 0.5 to 10.6 ± 0.6)
groups, but no change in the placebo group (8.0 ± 0.4 to
8.9 ± 0.4). For REPLE, however, there were increases from
day 0 to day 28 for all 3 groups (PEG1.25, 12.8 ± 0.8 to 19.7
± 1.6; PEG2.50, 12.8 ± 1.0 to 18.3 ± 1.6; placebo, 13.2 ± 0.9
to 18.6 ± 1.8). Previous studies have shown that shortterm high-dosage CM supplementation (21,37), but not
chronic low doses of PEG-creatine (19), improve upperand lower-body muscular endurance. For example, loading with 20 g · d-1 of CM for 5 days increased muscular endurance at 60% 1RM for bench press (16.1 ± 2.9 to 18.8 ±
3.5) and 70% 1RM for half squat (13.2 ± 3.0 to 15.9 ± 2.1)
(21). Warber et al. (37) also found that 24 g · d-1 of CM for
5 days resulted in significant increases in bench press repetitions to failure at 70% of 1RM (5 set total, 43.7 ± 6.9 to
50.7 ± 6.9) compared to placebo (41.4 ± 5.9 to 44.3 ± 5.9).
Herda et al. (19), however, demonstrated that increases in
bench press endurance (80% 1RM) and leg press endurance (80% 1RM) after 30 days of supplementation with 5
g · d-1 of CM, 1.25 g · d-1 of PEGcreatine, and 2.50 g · d-1 of
PEG-creatine were not significantly different from those
observed in the placebo group. Therefore, the results of
this study and Herda et al. (19) suggested that the influence of low-dose (1.25–2.50 g · d-1) PEG-creatine supplementation on muscular endurance in untrained individuals has not been clearly established. Furthermore, similar
to previously reported findings on muscular strength, it is
possible that supplementation with PEGcreatine may not
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influence measures of upper- and lower body muscular endurance in the same manner.
Although there is conflicting evidence (2,15,39), a
number of previous studies (8–10,13,16,21,27,36,37) have
shown increases in body mass of 1–2 kg after typical loading periods (5–6 days, 20–24 g · d-1) with CM. In this investigation, the PEG1.25 group exhibited increased body mass
from day 0 (79.8 ± 2.0 kg) to day 28 (80.7 ± 2.0 kg), but
not at day 14 (80.2 ± 2.0 kg). In addition, the PEG2.50 group
had increased body mass from day 0 (81.3 ± 2.1 kg) to day
14 (82.2 ± 2.1 kg) and day 28 (82.7 ± 2.1 kg). Changes
in body mass that are commonly observed with CM supplementation have been attributed to increased body water content as the result of increased cellular osmolarity
(20,36). Other findings (28,36), however, have suggested
that creatine supplementation may also promote increases
in FFM that are independent of those achieved with resistance training. For example, the cellular swelling that occurs during creatine supplementation because of increased
intracellular water accumulation may serve as a “universal
anabolic signal” (p. 140), thereby stimulating myofibrillar
protein synthesis (36). The findings of Parise et al. (28)
have also indicated that creatine may indirectly provide
anabolic effects through the inhibition of protein catabolism. In this study, however, there were increases in FFM
over the 28-day supplementation period for the PEG1.25
(67.8 ± 1.4 to 69.0 ± 1.4 kg), PEG2.50 (67.7 ± 1.5 to 69.0
± 1.5 kg), and placebo (66.7 ± 1.2 to 67.5 ± 1.3 kg) groups.
Based on these findings and the time course (28 days) of
this study, it is likely that the changes in body mass for the
PEG-creatine groups were the result of increased intramuscular water, phosphocreatine, or glycogen. Future studies
should further examine the relationships among PEG-creatine supplementation and body composition using various dosing protocols.
In summary, the present results indicated that supplementation with PEG-creatine led to improvements in vertical jump, 20-yard shuttle run, 3-cone drill, REPBP, and body
mass. Future studies should further examine the effects of
PEG-creatine supplementation on standardized anaerobic
performance measures, muscular strength and endurance
as well as body composition using larger doses or longer
supplementation periods.
Practical Applications
The results from this study indicated that PEG-creatine
supplementation (1.25 or 2.50 g · d-1) improved lowerbody vertical power, upper-body muscular endurance,
agility, change-of-direction ability, and body mass. Thus,
these findings support the use of the PEG-creatine supplement, at the dosages examined in this investigation,
as an ergogenic aid for increasing performance in vertical jump, REPBP, and body mass as well as improving 20yard shuttle run and 3-cone drill times in untrained individuals. For strength and conditioning coaches, personal
trainers, athletic trainers, physical therapists, educators,
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and other fitness professionals, the present results provide valuable information pertaining to supplementation
based on the needs and goals of a client or athlete. For example, the current PEG-creatine supplement may be most
beneficial at the initiation of a conditioning program or
preseason workout routine during which the client or athlete is in an untrained state. In particular, supplementation with PEG-creatine may enhance the ability to maintain high-intensity exercise, thereby improving training
capabilities and performance. For the individual involved
in recreational sports, these findings also suggested that
PEG-creatine supplementation may improve a number of
anaerobic performance measures without a concurrent resistance training program.
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